ANNEX I, Regulation (EU) 2016/161

In forcesince 11 Oct 2021cited 1×

Name of active substance or product category | Pharmaceutical form | Strength | Remarks

Homeopathic medicinal products | Any | Any |

Radionuclide generators | Any | Any |

Kits | Any | Any |

Radionuclide precursors | Any | Any |

Advanced therapy medicinal products which contain or consist of tissues or cells | Any | Any |

Medicinal gases | Medicinal gas | Any |

Solutions for parenteral nutrition having an anatomical therapeutical chemical (‘ATC’) code beginning with B05BA | Solution for infusion | Any |

Solutions affecting the electrolyte balance having an ATC code beginning with B05BB | Solution for infusion | Any |

Solutions producing osmotic diuresis having an ATC code beginning with B05BC | Solution for infusion | Any |

Intravenous solution additives having an ATC code beginning with B05X | Any | Any |

Solvents and diluting agents, including irrigating solutions, having an ATC code beginning with V07AB | Any | Any |

Contrast media having an ATC code beginning with V08 | Any | Any |

Tests for allergic diseases having an ATC code beginning with V04CL | Any | Any |

Allergen extracts having an ATC code beginning with V01AA | Any | Any |

Cicatrizants with ATC code D03AX | Fly larvae | |